Intercept Withdraws EU NASH Drug Filing But May Retry

Liver is a Part Human Body Internal Organs Anatomy. 3D
Intercept is collecting more data to support its drug for liver fibrosis due to NASH • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Product Reviews

More from Pink Sheet